V030-2189 Screening compound: 3-(2-fluorophenyl)-3-{1-[(4-methylphenyl)methyl]-1H-indol-3-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide

V030-2189 Screening compound: 3-(2-fluorophenyl)-3-{1-[(4-methylphenyl)methyl]-1H-indol-3-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide
V030-2189 Screening compound: 3-(2-fluorophenyl)-3-{1-[(4-methylphenyl)methyl]-1H-indol-3-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-2189
3-(2-fluorophenyl)-3-{1-[(4-methylphenyl)methyl]-1H-indol-3-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-2189

Molecular Formula

C31H34FN3O2 (C31 H34 FN3 O2)

Compound Name

3-(2-fluorophenyl)-3-{1-[(4-methylphenyl)methyl]-1H-indol-3-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide

IUPAC name

3-(2-fluorophenyl)-3-{1-[(4-methylphenyl)methyl]-1H-indol-3-yl}-N-[2-(morpholin-4-yl)ethyl]propanamide

SMILES

Cc1ccc(Cn2c(cccc3)c3c(C(CC(NCCN3CCOCC3)=O)c(cccc3)c3F)c2)cc1

InChI

InChI=1S/C31H34FN3O2/c1-23-10-12-24(13-11-23)21-35-22-28(26-7-3-5-9-30(26)35)27(25-6-2-4-8-29(25)32)20-31(36)33-14-15-34-16-18-37-19-17-34/h2-13,22,27H,14-21H2,1H3,(H,33,36)/t27-/m1/s1

InChI Key

BCKWYIWEYGPXTO-HHHXNRCGSA-N

MDL Number (MFCD)

MFCD19777791

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

499.63

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.625

Distribution Coefficient, logD

4.549

Water Solubility, LogSw

-4.04

Polar Surface Area

37.631

Acid Dissociation Constant (pKa)

12.78

Base Dissociation Constant (pKb)

6.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

32.30

V030-2189 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Indole Derivatives (10091 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • Cyclic compounds
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V030-2189 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-2189?
Check Price and Availability of V030-2189, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-2189 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-2189
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-2189
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-2189 available by request